PMID- 36418985 OWN - NLM STAT- MEDLINE DCOM- 20221125 LR - 20221213 IS - 1471-2407 (Electronic) IS - 1471-2407 (Linking) VI - 22 IP - 1 DP - 2022 Nov 22 TI - Co-designed weight management intervention for women recovering from oestrogen-receptor positive breast cancer. PG - 1202 LID - 10.1186/s12885-022-10287-y [doi] LID - 1202 AB - BACKGROUND: Weight gain is commonly observed during and after breast cancer treatment and is associated with poorer survival outcomes, particularly in women with oestrogen receptor-positive (ER +) disease. The aim of this study was to co-design (with patients) a programme of tailored, personalised support (intervention), including high-quality support materials, to help female breast cancer patients (BCPs) with ER + disease to develop the skills and confidence needed for sustainable weight loss. METHODS: ER + BCPs were recruited from two UK National Health Service (NHS) Trusts. The selection criteria included (i) recent experience of breast cancer treatment (within 36 months of completing primary treatment); (ii) participation in a recent focus group study investigating weight management perceptions and experiences; (iii) willingness to share experiences and contribute to discussions on the support structures needed for sustainable dietary and physical activity behaviour change. Co-design workshops included presentations and interactive activities and were facilitated by an experienced co-design researcher (HH), assisted by other members of the research team (KP, SW and JS). RESULTS: Two groups of BCPs from the North of England (N = 4) and South Yorkshire (N = 5) participated in a two-stage co-design process. The stage 1 and stage 2 co-design workshops were held two weeks apart and took place between Jan-March 2019, with each workshop being approximately 2 h in duration. Guided by the Behaviour Change Wheel, a theoretically-informed weight management intervention was developed on the basis of co-designed strategies to overcome physical and emotional barriers to dietary and physical activity behaviour change. BCPs were instrumental in designing all key features of the intervention, in terms of Capability (e.g., evidence-based information, peer-support and shared experiences), Opportunity (e.g., flexible approach to weight management based on core principles) and Motivation (e.g., appropriate use of goal-setting and high-quality resources, including motivational factsheets) for behaviour change. CONCLUSION: This co-design approach enabled the development of a theoretically-informed intervention with a content, structure and delivery model that has the potential to address the weight management challenges faced by BCPs diagnosed with ER + disease. Future research is required to evaluate the effectiveness of the intervention for eliciting clinically-important and sustainable weight loss in this population. CI - (c) 2022. The Author(s). FAU - Saxton, J M AU - Saxton JM AD - School of Sport, Exercise & Rehabilitation Sciences, Faculty of Health Sciences, University of Hull, Cottingham Road, Hull, HU6 7RX, UK. john.saxton@hull.ac.uk. FAU - Pickering, K AU - Pickering K AD - Advanced Wellbeing Research Centre, Sheffield Hallam University, Olympic Legacy Park 2 Old Hall Rd, Sheffield, S9 3TU, UK. FAU - Wane, S AU - Wane S AD - Department of Sport, Exercise and Rehabilitation, Northumbria University, City Campus, Newcastle-Upon-Tyne, NE1 8ST, UK. FAU - Humphreys, H AU - Humphreys H AD - Academy of Sport and Physical Activity, Sheffield Hallam University, Sheffield, S10 2BP, UK. FAU - Crank, H AU - Crank H AD - Academy of Sport and Physical Activity, Sheffield Hallam University, Sheffield, S10 2BP, UK. FAU - Anderson, A S AU - Anderson AS AD - Division of Population Health and Genomics, Centre for Research Into Cancer Prevention and Screening, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK. FAU - Cain, H AU - Cain H AD - Newcastle Upon Tyne Hospitals NHS Foundation Trust, Queen Victoria Road, Newcastle Upon Tyne, NE1 4LP, UK. FAU - Cohen, J AU - Cohen J AD - York Medical School, Hull Heath Trials Unit, University of Hull, Cottingham Road, HullHull, HU6 7RX, UK. FAU - Copeland, R J AU - Copeland RJ AD - Advanced Wellbeing Research Centre, Sheffield Hallam University, Olympic Legacy Park 2 Old Hall Rd, Sheffield, S9 3TU, UK. FAU - Gray, J AU - Gray J AD - Department of Nursing, Midwifery Are Health, Northumbria University, Coach Lane Campus, Newcastle Upon Tyne, NE7 7XA, UK. FAU - Hargreaves, J AU - Hargreaves J AD - Carnegie School of Sport, Leeds Beckett University, 9 Fairfax Hall, Headingley Campus, Leeds, LS6 3QS, UK. FAU - McNally, R J Q AU - McNally RJQ AD - Population Health Sciences Institute, Newcastle University GB, Newcastle Upon Tyne, NE1 7RU, UK. FAU - Wilson, C AU - Wilson C AD - Department of Oncology and Metabolism, The Medical School, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK. LA - eng GR - NOR416/YCR_/Yorkshire Cancer Research/United Kingdom GR - NOR416/YCR_/Yorkshire Cancer Research/United Kingdom GR - NOR416/YCR_/Yorkshire Cancer Research/United Kingdom GR - NOR416/YCR_/Yorkshire Cancer Research/United Kingdom GR - NOR416/YCR_/Yorkshire Cancer Research/United Kingdom GR - NOR416/YCR_/Yorkshire Cancer Research/United Kingdom GR - NOR416/YCR_/Yorkshire Cancer Research/United Kingdom GR - NOR416/YCR_/Yorkshire Cancer Research/United Kingdom GR - NOR416/YCR_/Yorkshire Cancer Research/United Kingdom GR - NOR416/YCR_/Yorkshire Cancer Research/United Kingdom PT - Journal Article DEP - 20221122 PL - England TA - BMC Cancer JT - BMC cancer JID - 100967800 RN - 0 (Estrogens) SB - IM MH - Humans MH - Female MH - *Breast Neoplasms MH - State Medicine MH - Weight Loss MH - Diet MH - Estrogens PMC - PMC9682743 OTO - NOTNLM OT - Breast cancer OT - Co-design OT - Obesity OT - Overweight OT - Weight loss intervention COIS- The authors declare that they have no competing interests. EDAT- 2022/11/25 06:00 MHDA- 2022/11/26 06:00 PMCR- 2022/11/22 CRDT- 2022/11/24 00:07 PHST- 2022/07/08 00:00 [received] PHST- 2022/10/06 00:00 [accepted] PHST- 2022/11/24 00:07 [entrez] PHST- 2022/11/25 06:00 [pubmed] PHST- 2022/11/26 06:00 [medline] PHST- 2022/11/22 00:00 [pmc-release] AID - 10.1186/s12885-022-10287-y [pii] AID - 10287 [pii] AID - 10.1186/s12885-022-10287-y [doi] PST - epublish SO - BMC Cancer. 2022 Nov 22;22(1):1202. doi: 10.1186/s12885-022-10287-y.